Clinical trial
Gene Therapy in Treating Patients With Advanced Head and Neck Cancer
NCT00009841 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00009841 |
|---|---|
| Title | Gene Therapy in Treating Patients With Advanced Head and Neck Cancer |
| Official title | Phase I Trial Of Intratumoral EGFR Antisense DNA And DC-Chol Liposomes In Advanced Oral Squamous Cell Carcinoma |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Biological, Drug |
| Interventions | EGFR antisense DNA, growth factor antagonist therapy, DC-cholesterol liposome |
| Enrollment | 13 |
| Start date | Mar 1, 1999 |
| Primary completion | Mar 1, 2002 |
| Completion | Mar 1, 2002 |
| First posted | Apr 2, 2004 |
| Last update posted | Feb 12, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: